Page last updated: 2024-11-05

trihexyphenidyl and Long Sleeper Syndrome

trihexyphenidyl has been researched along with Long Sleeper Syndrome in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keshavan, MS1
Burton, S1
Murphy, M1
Checkley, SA1
Crammer, JL1
Martin, WE1
Loewenson, RB1
Resch, JA1
Baker, AB1
Dusek, K1
Janík, A1

Trials

1 trial available for trihexyphenidyl and Long Sleeper Syndrome

ArticleYear
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Neurology, 1974, Volume: 24, Issue:10

    Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therap

1974

Other Studies

2 other studies available for trihexyphenidyl and Long Sleeper Syndrome

ArticleYear
Benzhexol withdrawal and cholinergic mechanisms in depression.
    The British journal of psychiatry : the journal of mental science, 1985, Volume: 147

    Topics: Adult; Cholinergic Fibers; Depression; Hallucinations; Humans; Male; Memory; Recurrence; Sleep Wake

1985
[Forms of dependency on psychopharmaceutic drugs and sleep disorders].
    Activitas nervosa superior, 1968, Volume: 10, Issue:2

    Topics: Humans; Mental Disorders; Sleep Wake Disorders; Substance Withdrawal Syndrome; Substance-Related Dis

1968